Targeted T-cell Immunotherapy
A treatment for new COVID-19 patients. Administered by inhaler.
Designed to prevent severe COVID-19 disease and cure COVID ‘long-haulers’.
Vaccination by Inhalation. FLOVID-20 uses inhalational delivery of a preventative and therapeutic immuno-stimulatory biomedicine targeting nucleocapsid epitopes on SARS-CoV-2.
COVID-19 Mutations are Rising—FLOVID-20 can create a strong line of defense to fight COVID-19 variants where the infections occur, in the lungs, and our approach is validated by recent independent work at MIT.